Skip to main content
PDSB
NASDAQ Life Sciences

PDS Biotechnologyが2025年に終了々74セントの秒対値を拡撑

feedReported by Dow Jones Newswires
Sentiment info
Negative
Importance info
8
Price
$0.57
Mkt Cap
$29.626M
52W Low
$0.523
52W High
$1.915
Market data snapshot near publication time

summarizeSummary

PDS Biotechnologyは2025年平年に$0.74の秒対値を拡撑した。こたは終了な財組结果です、すでもコンパニの現在の肥位は$0.57までです。現在の肥位を超えた秒対値は終了な本育性としなコンパニの財組政府に関する感情を上書するためです。トレーターはこたに对すての値の渐査をコンパニの肥位と操作値値を上書する必要を終了に設定に对せることがある。

この発表時点で、PDSBは$0.57で取引されており、市場はNASDAQ、セクターはLife Sciences、時価総額は約$2962.6万でした。 52週の取引レンジは$0.52から$1.92でした。 このニュースはネガティブの市場センチメント、重要度スコア8/10と評価されました。 出典：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed PDSB - Latest Insights

PDSB
Apr 27, 2026, 11:51 AM EDT
Filing Type: S-3/A
Importance Score:
9
PDS Biotech Files $200M Universal Shelf Registration Following Positive Phase 2 Data
Sentiment: Negative
View Wiseek Article
PDSB
Apr 15, 2026, 8:45 AM EDT
Source: GlobeNewswire
Importance Score:
9
PDS01ADC Shows 78% ORR, >80% 2-Year Survival in mCRC Phase 2 Trial, Data Published
Sentiment: Positive
View Wiseek Article
PDSB
Mar 30, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
9
PDS Biotech Amends Phase 3 Trial for Accelerated Approval Pathway, Reports Encouraging Clinical Data
Sentiment: Positive
View Wiseek Article
PDSB
Mar 30, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
PDS Biotechnology Reports Significant 74-Cent Per Share Loss for 2025
Sentiment: Negative
View Wiseek Article
PDSB
Mar 03, 2026, 12:03 PM EST
Source: Wiseek News
Importance Score:
8
PDS Biotechnology Receives Nasdaq Deficiency Notice for Minimum Bid Price
Sentiment: Negative
View Wiseek Article
PDSB
Mar 03, 2026, 12:01 PM EST
Filing Type: 8-K
Importance Score:
9
PDS Biotechnology Receives Nasdaq Delisting Notice for Minimum Bid Price Non-Compliance
Sentiment: Negative
View Wiseek Article
PDSB
Feb 20, 2026, 8:35 AM EST
Filing Type: 8-K
Importance Score:
8
PDS Biotech Adopts Amended Phase 3 Protocol for Accelerated Approval Pathway of PDS0101
Sentiment: Positive
View Wiseek Article
PDSB
Jan 28, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
PDS Biotech's PDS01ADC Shows Promising Phase 2 Results in Advanced Prostate Cancer
Sentiment: Positive
View Wiseek Article
PDSB
Jan 22, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
PDS Biotech Secures Key U.S. Patent for Lead Cancer Immunotherapy PDS0101, Extending Market Protection
Sentiment: Positive
View Wiseek Article
PDSB
Jan 09, 2026, 8:50 AM EST
Filing Type: 8-K
Importance Score:
8
PDS Biotech Submits Phase 3 Protocol Amendment for Accelerated PDS0101 Approval Pathway
Sentiment: Positive
View Wiseek Article